Bendamustine conditioning for refractory type I cryoglobulinemia

Joint Bone Spine. 2016 Oct;83(5):591-2. doi: 10.1016/j.jbspin.2015.07.007. Epub 2015 Dec 8.
No abstract available

Keywords: Bendamustine; Cryoglobulinemia; Gammopathy of undertermined significance.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Autografts
  • Bendamustine Hydrochloride / therapeutic use*
  • Cryoglobulinemia / drug therapy*
  • Cryoglobulinemia / therapy
  • Female
  • Humans
  • Monoclonal Gammopathy of Undetermined Significance / drug therapy
  • Monoclonal Gammopathy of Undetermined Significance / therapy
  • Stem Cell Transplantation

Substances

  • Antineoplastic Agents, Alkylating
  • Bendamustine Hydrochloride